Evidence map›Paper›PMID 28144786›Full record

Observational studyInternational journal of hematology2017

Serum concentrations of apoptosis-associated molecules in septic children with leukemia, neutropenia and fever.

Jesus Reyna-Figueroa, Alfredo Lagunas-Martínez, Patricia Galindo-Delgado, María Fernanda Fernández-Bautista, Paola Guadalupe Castro-Oteo, Pilar Martínez-Matsumoto, Erika Melchy Perez, Yvonne Rosenstein, Ana Elena Limón-Rojas, Federico Javier Ortiz-Ibarra and 1 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in International journal of hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Jesus Reyna-FigueroaPediatrics Service, South Central Hospital of High Specialty of Petroleos Mexicanos, Health Services of Petroleos Mexicanos, Dirección: Blvd. Adolfo Ruiz Cortines 4091, Tlalpan, Fuentes del Pedregal, 14140, Mexico City, DF, Mexico. jesusreynaf@gmail.com.
Alfredo Lagunas-MartínezCentre for Research on Infectious Diseases, National Institute of Public Health, Secretary of Health, Cuernavaca, Morelos, Mexico.
Patricia Galindo-DelgadoPediatrics Service, South Central Hospital of High Specialty of Petroleos Mexicanos, Health Services of Petroleos Mexicanos, Dirección: Blvd. Adolfo Ruiz Cortines 4091, Tlalpan, Fuentes del Pedregal, 14140, Mexico City, DF, Mexico.
María Fernanda Fernández-BautistaPediatrics Service, South Central Hospital of High Specialty of Petroleos Mexicanos, Health Services of Petroleos Mexicanos, Dirección: Blvd. Adolfo Ruiz Cortines 4091, Tlalpan, Fuentes del Pedregal, 14140, Mexico City, DF, Mexico.
Paola Guadalupe Castro-OteoPediatrics Service, South Central Hospital of High Specialty of Petroleos Mexicanos, Health Services of Petroleos Mexicanos, Dirección: Blvd. Adolfo Ruiz Cortines 4091, Tlalpan, Fuentes del Pedregal, 14140, Mexico City, DF, Mexico.
Pilar Martínez-MatsumotoPediatrics Service, South Central Hospital of High Specialty of Petroleos Mexicanos, Health Services of Petroleos Mexicanos, Dirección: Blvd. Adolfo Ruiz Cortines 4091, Tlalpan, Fuentes del Pedregal, 14140, Mexico City, DF, Mexico.
Erika Melchy PerezDepartment of Molecular Medicine and Bioprocesses, Institute of Biotechnology, National Autonomous University of Mexico, Mexico City, Mexico.
Yvonne RosensteinDepartment of Molecular Medicine and Bioprocesses, Institute of Biotechnology, National Autonomous University of Mexico, Mexico City, Mexico.
Ana Elena Limón-RojasPediatrics Service, South Central Hospital of High Specialty of Petroleos Mexicanos, Health Services of Petroleos Mexicanos, Dirección: Blvd. Adolfo Ruiz Cortines 4091, Tlalpan, Fuentes del Pedregal, 14140, Mexico City, DF, Mexico.
Federico Javier Ortiz-IbarraPaediatric Infectology Service, Hospital Angeles del Pedregal, Magdalena Contreras, Mexico.
Vicente Madrid-MarinaCentre for Research on Infectious Diseases, National Institute of Public Health, Secretary of Health, Cuernavaca, Morelos, Mexico.
Pemex (Mexico) · MXNational Institute of Public Health · LAUniversidad Nacional Autónoma de México · MXHospital Angeles Pedregal · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been shown that Fas, Fas-L, TNF and TNFR-1 display high serum concentrations in subjects with sepsis. This suggests that these are potential severity markers. However, the serum concentration of these molecules in children with leukemia and suspected sepsis has to be established before proposing their use as diagnostic biomarkers. We included children <17 years of age diagnosed with acute lymphoblastic leukemia with neutropenia and fever (NF). The subjects were divided into two groups: (1) leukemia and NF with sepsis, (2) leukemia and NF without sepsis. Determination of serum levels of TNF-α, TNFR-1, Fas and Fas-L was performed using ELISA tests, and apoptosis percentage using flow cytometry. Seventy-two subjects with ALL and NF were included in the two groups. The highest serum levels of TNF-α (35.2 ± 7.6 pg/ml) and TNF-R1 (4102 ± 2440) and the lowest levels of Fas-L (19.4 ± 7.3 pg/ml) were found in group 2: however, the difference in comparison with patients without sepsis was not statistically significant. Low levels of Fas-L and low percentage of apoptotic cells are observed in septic subjects. This pattern may reflect the presence of sepsis among subjects with NF secondary to leukemia.

Indexed as

AdolescentBiomarkersChildFas Ligand Proteinfas ReceptorFemaleFeverHumansMaleNeutropeniaPrecursor Cell Lymphoblastic Leukemia-LymphomaProspective StudiesReceptors, Tumor Necrosis Factor, Type ISepsisSeverity of Illness IndexTumor Necrosis Factor-alphaBiomarkersFas Ligand ProteinFAS protein, humanfas ReceptorReceptors, Tumor Necrosis Factor, Type ITumor Necrosis Factor-alphaApoptosisFasFas-LLeukemiaNeutropenia and feverSepsisTNF-R1TNF-α

Identifiers

PMID28144786
OpenAlexW2585457285

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.